Short answer
AdaptHealth Corp. (AHCO) filed its Q3 2026 10-Q quarterly report on Nov 3, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $746M (down 9.1% year over year) with net income of −$154M.
Q3 2026 key financials · XBRL
- Revenue
- $746M
- −9.1% YoY · +24.2% QoQ
- Net income
- −$154M
- −728.3% YoY · −15.0% QoQ
- Operating margin
- -20.9%
- EPS (diluted)
- −$1.14
- −812.5% YoY · −16.3% QoQ
Source: XBRL data from the AdaptHealth Corp. (AHCO) Q3 2026 10-Q on SEC EDGAR. USD.
AdaptHealth Corp. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $745.6M, up 10.9% YoY from $672.4M, driven by capitated revenue arrangements at 14.8% vs 4.7%
- Operating margin (20.9%) vs 6.5% YoY, including $184.8M goodwill impairment; Adjusted EBITDA margin 19.0% vs 21.7%
- Best segment: Respiratory Health revenue $190.8M, up 7.8%, Adjusted EBITDA margin 29.5% vs 29.0%; worst: Wellness margin 9.3% vs 12.7%
- Cash $80.7M; operating cash flow $156.6M, free cash flow $51.1M vs $66.8M YoY, reflecting $105.5M equipment purchases
- Near-term outlook: liquidity sufficient for at least twelve months; inflation, supply-chain costs, cybersecurity remediation and capitated equipment spending remain headwinds
Risk Factors
- Newly added supplier risk: Medline’s October 2026 field action removed all Medline Brand beds and related products from availability
- Operational impact: Replacement beds may be unavailable timely or on similar terms, limiting patient-demand fulfillment
- Regulatory risk: Medline cited potential electrical-system fire and entrapment hazards involving bed accessories
- Financial risk: Field action may create significant unrecoverable costs for AdaptHealth
- Supply-chain risk: Tariffs or excise taxes could increase patient-service equipment procurement costs
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other AdaptHealth Corp. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.